Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-30

FDA Approved: PLERIXAFOR — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for plerixafor from Dr. Reddy's Laboratories, typically resulting in a labeling or usage modification for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)